KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	137,861	166,982	257,943	233,403	529,520	242,129
Market Cap Growth	-18.97%	-35.26%	10.51%	-55.92%	118.69%	-
Enterprise Value	142,671	151,067	248,815	222,946	528,191	235,248
Last Close Price	12640.00	15251.21	23482.14	21200.57	47987.24	21920.01
PE Ratio	791.60	44.04	3079.40	-	83.15	76.65
Forward PE	-	82.10	82.10	82.10	112.13	39.78
PS Ratio	1.53	2.05	3.10	2.88	6.65	3.39
PB Ratio	1.94	2.34	3.76	3.90	9.21	5.21
P/TBV Ratio	2.04	2.48	3.96	4.10	9.72	5.50
P/FCF Ratio	-	34.81	78.44	40.14	114.12	-
P/OCF Ratio	26.17	20.75	53.52	28.19	73.62	-
EV/Sales Ratio	1.58	1.86	2.99	2.75	6.64	3.29
EV/EBITDA Ratio	17.83	17.01	28.75	26.02	71.46	34.47
EV/EBIT Ratio	29.11	24.82	42.60	36.03	105.34	51.10
EV/FCF Ratio	-8.65	31.49	75.67	38.34	113.83	-
Debt / Equity Ratio	0.54	0.32	0.51	0.91	0.94	0.30
Debt / EBITDA Ratio	5.93	2.58	4.03	6.38	7.27	2.04
Debt / FCF Ratio	-	4.77	10.60	9.40	11.58	-
Asset Turnover	0.75	0.70	0.66	0.62	0.76	0.97
Inventory Turnover	2.59	2.46	2.59	2.67	2.40	2.30
Quick Ratio	1.17	2.76	1.89	1.14	3.13	1.13
Current Ratio	1.70	3.81	2.56	1.41	3.81	1.79
Return on Equity (ROE)	0.24%	5.42%	0.13%	-1.91%	12.25%	8.64%
Return on Assets (ROA)	1.74%	3.26%	2.89%	2.97%	2.97%	3.89%
Return on Invested Capital (ROIC)	4.34%	10.57%	0.46%	12.37%	11.11%	10.32%
Return on Capital Employed (ROCE)	3.80%	6.50%	6.60%	10.10%	4.80%	9.10%
Earnings Yield	0.13%	2.27%	0.03%	-0.48%	1.20%	1.31%
FCF Yield	-11.96%	2.87%	1.27%	2.49%	0.88%	-1.18%
Payout Ratio	313.13%	14.38%	651.04%	-	8.56%	13.91%
Buyback Yield / Dilution	-15.73%	-15.33%	3.63%	1.22%	-12.80%	-10.95%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.